nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—AR—prostate cancer	0.11	0.336	CbGaD
Mifepristone—CYP3A5—prostate cancer	0.0998	0.305	CbGaD
Mifepristone—NR3C1—prostate cancer	0.0745	0.228	CbGaD
Mifepristone—AR—Nilutamide—prostate cancer	0.0601	0.131	CbGbCtD
Mifepristone—AR—Bicalutamide—prostate cancer	0.0601	0.131	CbGbCtD
Mifepristone—AR—Flutamide—prostate cancer	0.0498	0.109	CbGbCtD
Mifepristone—CYP3A4—prostate cancer	0.0432	0.132	CbGaD
Mifepristone—ABCC1—Abiraterone—prostate cancer	0.0306	0.0668	CbGbCtD
Mifepristone—AR—Estradiol—prostate cancer	0.0207	0.0451	CbGbCtD
Mifepristone—ABCC1—Conjugated Estrogens—prostate cancer	0.0145	0.0316	CbGbCtD
Mifepristone—ABCC1—Mitoxantrone—prostate cancer	0.0131	0.0287	CbGbCtD
Mifepristone—CYP3A5—Flutamide—prostate cancer	0.0113	0.0247	CbGbCtD
Mifepristone—NR3C1—Prednisone—prostate cancer	0.0113	0.0247	CbGbCtD
Mifepristone—ABCC1—Epirubicin—prostate cancer	0.0106	0.0232	CbGbCtD
Mifepristone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0102	0.0222	CbGbCtD
Mifepristone—CYP2D6—Bicalutamide—prostate cancer	0.00839	0.0183	CbGbCtD
Mifepristone—CYP3A5—Cabazitaxel—prostate cancer	0.00839	0.0183	CbGbCtD
Mifepristone—ABCC1—Etoposide—prostate cancer	0.00829	0.0181	CbGbCtD
Mifepristone—ABCB1—Estramustine—prostate cancer	0.00828	0.0181	CbGbCtD
Mifepristone—CYP3A5—Estrone—prostate cancer	0.0082	0.0179	CbGbCtD
Mifepristone—ABCC1—Docetaxel—prostate cancer	0.00759	0.0166	CbGbCtD
Mifepristone—CYP2D6—Abiraterone—prostate cancer	0.00695	0.0152	CbGbCtD
Mifepristone—CYP3A7—Estradiol—prostate cancer	0.00628	0.0137	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00628	0.0137	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—prostate cancer	0.00565	0.0123	CbGbCtD
Mifepristone—ABCB1—Cabazitaxel—prostate cancer	0.00546	0.0119	CbGbCtD
Mifepristone—CYP3A4—Bicalutamide—prostate cancer	0.00534	0.0116	CbGbCtD
Mifepristone—ABCB1—Estrone—prostate cancer	0.00533	0.0116	CbGbCtD
Mifepristone—CYP3A4—Estramustine—prostate cancer	0.00496	0.0108	CbGbCtD
Mifepristone—ABCB1—Ethinyl Estradiol—prostate cancer	0.00475	0.0104	CbGbCtD
Mifepristone—CYP3A5—Estradiol—prostate cancer	0.00471	0.0103	CbGbCtD
Mifepristone—CYP3A4—Flutamide—prostate cancer	0.00442	0.00965	CbGbCtD
Mifepristone—CYP3A4—Abiraterone—prostate cancer	0.00442	0.00965	CbGbCtD
Mifepristone—CYP3A7—Docetaxel—prostate cancer	0.00375	0.00818	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00375	0.00818	CbGbCtD
Mifepristone—ABCB1—Conjugated Estrogens—prostate cancer	0.00349	0.00762	CbGbCtD
Mifepristone—CYP3A4—Cabazitaxel—prostate cancer	0.00327	0.00714	CbGbCtD
Mifepristone—CYP3A4—Estrone—prostate cancer	0.0032	0.00698	CbGbCtD
Mifepristone—ABCB1—Mitoxantrone—prostate cancer	0.00317	0.00693	CbGbCtD
Mifepristone—CYP3A5—Etoposide—prostate cancer	0.00307	0.00671	CbGbCtD
Mifepristone—AR—penis—prostate cancer	0.00307	0.13	CbGeAlD
Mifepristone—ABCB1—Estradiol—prostate cancer	0.00306	0.00669	CbGbCtD
Mifepristone—AR—semen—prostate cancer	0.00292	0.124	CbGeAlD
Mifepristone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00285	0.00622	CbGbCtD
Mifepristone—CYP3A5—Docetaxel—prostate cancer	0.00281	0.00614	CbGbCtD
Mifepristone—ABCB1—Prednisone—prostate cancer	0.00263	0.00575	CbGbCtD
Mifepristone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00209	0.00456	CbGbCtD
Mifepristone—ABCB1—Etoposide—prostate cancer	0.002	0.00437	CbGbCtD
Mifepristone—CYP3A4—Mitoxantrone—prostate cancer	0.0019	0.00415	CbGbCtD
Mifepristone—CYP3A4—Estradiol—prostate cancer	0.00184	0.00401	CbGbCtD
Mifepristone—ABCB1—Docetaxel—prostate cancer	0.00183	0.004	CbGbCtD
Mifepristone—CYP3A4—Prednisone—prostate cancer	0.00158	0.00345	CbGbCtD
Mifepristone—NR3C1—urine—prostate cancer	0.00148	0.0628	CbGeAlD
Mifepristone—ABCB1—Doxorubicin—prostate cancer	0.00136	0.00298	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—prostate cancer	0.00129	0.00281	CbGbCtD
Mifepristone—CYP3A4—Etoposide—prostate cancer	0.0012	0.00262	CbGbCtD
Mifepristone—CYP3A4—urine—prostate cancer	0.00112	0.0475	CbGeAlD
Mifepristone—CYP2D6—urine—prostate cancer	0.0011	0.0467	CbGeAlD
Mifepristone—CYP3A4—Docetaxel—prostate cancer	0.0011	0.00239	CbGbCtD
Mifepristone—PGR—prostate gland—prostate cancer	0.00092	0.039	CbGeAlD
Mifepristone—CYP3A4—Doxorubicin—prostate cancer	0.000818	0.00178	CbGbCtD
Mifepristone—AR—prostate gland—prostate cancer	0.000733	0.0311	CbGeAlD
Mifepristone—ABCC1—prostate gland—prostate cancer	0.000696	0.0295	CbGeAlD
Mifepristone—PGR—epithelium—prostate cancer	0.000676	0.0287	CbGeAlD
Mifepristone—AR—seminal vesicle—prostate cancer	0.00062	0.0263	CbGeAlD
Mifepristone—ABCC1—seminal vesicle—prostate cancer	0.000589	0.025	CbGeAlD
Mifepristone—AR—epithelium—prostate cancer	0.000539	0.0229	CbGeAlD
Mifepristone—CYP3A5—prostate gland—prostate cancer	0.000535	0.0227	CbGeAlD
Mifepristone—NR3C1—prostate gland—prostate cancer	0.000531	0.0225	CbGeAlD
Mifepristone—AR—renal system—prostate cancer	0.0005	0.0212	CbGeAlD
Mifepristone—AR—urethra—prostate cancer	0.000491	0.0208	CbGeAlD
Mifepristone—ABCC1—urethra—prostate cancer	0.000466	0.0198	CbGeAlD
Mifepristone—NR3C1—seminal vesicle—prostate cancer	0.000449	0.0191	CbGeAlD
Mifepristone—PGR—testis—prostate cancer	0.000405	0.0172	CbGeAlD
Mifepristone—NR3C1—epithelium—prostate cancer	0.00039	0.0166	CbGeAlD
Mifepristone—CYP3A5—renal system—prostate cancer	0.000365	0.0155	CbGeAlD
Mifepristone—NR3C1—renal system—prostate cancer	0.000362	0.0154	CbGeAlD
Mifepristone—NR3C1—urethra—prostate cancer	0.000355	0.0151	CbGeAlD
Mifepristone—AR—testis—prostate cancer	0.000323	0.0137	CbGeAlD
Mifepristone—ABCC1—testis—prostate cancer	0.000307	0.013	CbGeAlD
Mifepristone—PGR—lymph node—prostate cancer	0.000294	0.0125	CbGeAlD
Mifepristone—ABCB1—prostate gland—prostate cancer	0.000284	0.0121	CbGeAlD
Mifepristone—CYP3A4—renal system—prostate cancer	0.000274	0.0116	CbGeAlD
Mifepristone—NR3C1—bone marrow—prostate cancer	0.000274	0.0116	CbGeAlD
Mifepristone—CYP2D6—renal system—prostate cancer	0.000269	0.0114	CbGeAlD
Mifepristone—ABCB1—seminal vesicle—prostate cancer	0.00024	0.0102	CbGeAlD
Mifepristone—AR—lymph node—prostate cancer	0.000234	0.00993	CbGeAlD
Mifepristone—NR3C1—testis—prostate cancer	0.000234	0.00993	CbGeAlD
Mifepristone—ABCC1—lymph node—prostate cancer	0.000222	0.00943	CbGeAlD
Mifepristone—ABCB1—epithelium—prostate cancer	0.000209	0.00886	CbGeAlD
Mifepristone—ABCB1—renal system—prostate cancer	0.000194	0.00822	CbGeAlD
Mifepristone—ABCB1—urethra—prostate cancer	0.00019	0.00808	CbGeAlD
Mifepristone—CYP2D6—testis—prostate cancer	0.000174	0.00739	CbGeAlD
Mifepristone—NR3C1—lymph node—prostate cancer	0.00017	0.00719	CbGeAlD
Mifepristone—ABCB1—bone marrow—prostate cancer	0.000146	0.00622	CbGeAlD
Mifepristone—ABCB1—testis—prostate cancer	0.000125	0.00531	CbGeAlD
Mifepristone—ABCB1—lymph node—prostate cancer	9.08e-05	0.00385	CbGeAlD
Mifepristone—Dyspnoea—Etoposide—prostate cancer	4.67e-05	0.000397	CcSEcCtD
Mifepristone—Malaise—Capecitabine—prostate cancer	4.65e-05	0.000396	CcSEcCtD
Mifepristone—Somnolence—Etoposide—prostate cancer	4.65e-05	0.000396	CcSEcCtD
Mifepristone—Hypersensitivity—Mitoxantrone—prostate cancer	4.64e-05	0.000395	CcSEcCtD
Mifepristone—Mental disorder—Prednisone—prostate cancer	4.63e-05	0.000394	CcSEcCtD
Mifepristone—Diarrhoea—Estradiol—prostate cancer	4.62e-05	0.000393	CcSEcCtD
Mifepristone—Hypertension—Docetaxel—prostate cancer	4.6e-05	0.000392	CcSEcCtD
Mifepristone—Infestation NOS—Epirubicin—prostate cancer	4.6e-05	0.000392	CcSEcCtD
Mifepristone—Infestation—Epirubicin—prostate cancer	4.6e-05	0.000392	CcSEcCtD
Mifepristone—Malnutrition—Prednisone—prostate cancer	4.6e-05	0.000391	CcSEcCtD
Mifepristone—Decreased appetite—Etoposide—prostate cancer	4.55e-05	0.000387	CcSEcCtD
Mifepristone—Myalgia—Docetaxel—prostate cancer	4.54e-05	0.000386	CcSEcCtD
Mifepristone—Arthralgia—Docetaxel—prostate cancer	4.54e-05	0.000386	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Etoposide—prostate cancer	4.52e-05	0.000385	CcSEcCtD
Mifepristone—Asthenia—Mitoxantrone—prostate cancer	4.52e-05	0.000384	CcSEcCtD
Mifepristone—Fatigue—Etoposide—prostate cancer	4.51e-05	0.000384	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.51e-05	0.000384	CcSEcCtD
Mifepristone—Pain—Etoposide—prostate cancer	4.48e-05	0.000381	CcSEcCtD
Mifepristone—Constipation—Etoposide—prostate cancer	4.48e-05	0.000381	CcSEcCtD
Mifepristone—Dizziness—Estradiol—prostate cancer	4.47e-05	0.00038	CcSEcCtD
Mifepristone—Hypertension—Capecitabine—prostate cancer	4.46e-05	0.000379	CcSEcCtD
Mifepristone—Dry mouth—Docetaxel—prostate cancer	4.44e-05	0.000378	CcSEcCtD
Mifepristone—Myalgia—Capecitabine—prostate cancer	4.39e-05	0.000374	CcSEcCtD
Mifepristone—Arthralgia—Capecitabine—prostate cancer	4.39e-05	0.000374	CcSEcCtD
Mifepristone—Anxiety—Capecitabine—prostate cancer	4.38e-05	0.000373	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.36e-05	0.000371	CcSEcCtD
Mifepristone—Oedema—Docetaxel—prostate cancer	4.35e-05	0.00037	CcSEcCtD
Mifepristone—Discomfort—Capecitabine—prostate cancer	4.34e-05	0.00037	CcSEcCtD
Mifepristone—Infection—Docetaxel—prostate cancer	4.32e-05	0.000368	CcSEcCtD
Mifepristone—Sinusitis—Epirubicin—prostate cancer	4.32e-05	0.000367	CcSEcCtD
Mifepristone—Feeling abnormal—Etoposide—prostate cancer	4.31e-05	0.000367	CcSEcCtD
Mifepristone—Diarrhoea—Mitoxantrone—prostate cancer	4.31e-05	0.000367	CcSEcCtD
Mifepristone—Dry mouth—Capecitabine—prostate cancer	4.3e-05	0.000366	CcSEcCtD
Mifepristone—Vomiting—Estradiol—prostate cancer	4.29e-05	0.000366	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—prostate cancer	4.28e-05	0.000364	CcSEcCtD
Mifepristone—Nervous system disorder—Docetaxel—prostate cancer	4.27e-05	0.000363	CcSEcCtD
Mifepristone—Ill-defined disorder—Prednisone—prostate cancer	4.27e-05	0.000363	CcSEcCtD
Mifepristone—Rash—Estradiol—prostate cancer	4.26e-05	0.000362	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—prostate cancer	4.26e-05	0.000362	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—prostate cancer	4.26e-05	0.000362	CcSEcCtD
Mifepristone—Dermatitis—Estradiol—prostate cancer	4.25e-05	0.000362	CcSEcCtD
Mifepristone—Headache—Estradiol—prostate cancer	4.23e-05	0.00036	CcSEcCtD
Mifepristone—Skin disorder—Docetaxel—prostate cancer	4.23e-05	0.00036	CcSEcCtD
Mifepristone—Oedema—Capecitabine—prostate cancer	4.21e-05	0.000359	CcSEcCtD
Mifepristone—Angioedema—Prednisone—prostate cancer	4.2e-05	0.000358	CcSEcCtD
Mifepristone—Infection—Capecitabine—prostate cancer	4.18e-05	0.000356	CcSEcCtD
Mifepristone—Urticaria—Etoposide—prostate cancer	4.16e-05	0.000354	CcSEcCtD
Mifepristone—Haemoglobin—Epirubicin—prostate cancer	4.15e-05	0.000353	CcSEcCtD
Mifepristone—Anorexia—Docetaxel—prostate cancer	4.15e-05	0.000353	CcSEcCtD
Mifepristone—Malaise—Prednisone—prostate cancer	4.15e-05	0.000353	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—prostate cancer	4.14e-05	0.000352	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—prostate cancer	4.14e-05	0.000352	CcSEcCtD
Mifepristone—Nervous system disorder—Capecitabine—prostate cancer	4.13e-05	0.000352	CcSEcCtD
Mifepristone—Haemorrhage—Epirubicin—prostate cancer	4.13e-05	0.000352	CcSEcCtD
Mifepristone—Skin disorder—Capecitabine—prostate cancer	4.09e-05	0.000348	CcSEcCtD
Mifepristone—Oedema peripheral—Epirubicin—prostate cancer	4.07e-05	0.000346	CcSEcCtD
Mifepristone—Hypotension—Docetaxel—prostate cancer	4.07e-05	0.000346	CcSEcCtD
Mifepristone—Connective tissue disorder—Epirubicin—prostate cancer	4.06e-05	0.000345	CcSEcCtD
Mifepristone—Anorexia—Capecitabine—prostate cancer	4.02e-05	0.000342	CcSEcCtD
Mifepristone—Nausea—Estradiol—prostate cancer	4.01e-05	0.000341	CcSEcCtD
Mifepristone—Vomiting—Mitoxantrone—prostate cancer	4e-05	0.000341	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—prostate cancer	3.99e-05	0.00034	CcSEcCtD
Mifepristone—Hypertension—Prednisone—prostate cancer	3.97e-05	0.000338	CcSEcCtD
Mifepristone—Rash—Mitoxantrone—prostate cancer	3.97e-05	0.000338	CcSEcCtD
Mifepristone—Dermatitis—Mitoxantrone—prostate cancer	3.96e-05	0.000337	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.96e-05	0.000337	CcSEcCtD
Mifepristone—Headache—Mitoxantrone—prostate cancer	3.94e-05	0.000336	CcSEcCtD
Mifepristone—Hypotension—Capecitabine—prostate cancer	3.94e-05	0.000335	CcSEcCtD
Mifepristone—Insomnia—Docetaxel—prostate cancer	3.93e-05	0.000335	CcSEcCtD
Mifepristone—Arthralgia—Prednisone—prostate cancer	3.91e-05	0.000333	CcSEcCtD
Mifepristone—Myalgia—Prednisone—prostate cancer	3.91e-05	0.000333	CcSEcCtD
Mifepristone—Anxiety—Prednisone—prostate cancer	3.9e-05	0.000332	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.89e-05	0.000331	CcSEcCtD
Mifepristone—Dyspnoea—Docetaxel—prostate cancer	3.88e-05	0.00033	CcSEcCtD
Mifepristone—Somnolence—Docetaxel—prostate cancer	3.87e-05	0.000329	CcSEcCtD
Mifepristone—Discomfort—Prednisone—prostate cancer	3.87e-05	0.000329	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—prostate cancer	3.86e-05	0.000328	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—prostate cancer	3.84e-05	0.000327	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.84e-05	0.000327	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—prostate cancer	3.82e-05	0.000325	CcSEcCtD
Mifepristone—Insomnia—Capecitabine—prostate cancer	3.81e-05	0.000324	CcSEcCtD
Mifepristone—Decreased appetite—Docetaxel—prostate cancer	3.78e-05	0.000322	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—prostate cancer	3.76e-05	0.00032	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Docetaxel—prostate cancer	3.76e-05	0.00032	CcSEcCtD
Mifepristone—Asthenia—Etoposide—prostate cancer	3.76e-05	0.00032	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—prostate cancer	3.76e-05	0.00032	CcSEcCtD
Mifepristone—Dyspnoea—Capecitabine—prostate cancer	3.76e-05	0.00032	CcSEcCtD
Mifepristone—Oedema—Prednisone—prostate cancer	3.75e-05	0.000319	CcSEcCtD
Mifepristone—Fatigue—Docetaxel—prostate cancer	3.75e-05	0.000319	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—prostate cancer	3.75e-05	0.000319	CcSEcCtD
Mifepristone—Nausea—Mitoxantrone—prostate cancer	3.74e-05	0.000318	CcSEcCtD
Mifepristone—Infection—Prednisone—prostate cancer	3.73e-05	0.000317	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—prostate cancer	3.72e-05	0.000317	CcSEcCtD
Mifepristone—Constipation—Docetaxel—prostate cancer	3.72e-05	0.000317	CcSEcCtD
Mifepristone—Pain—Docetaxel—prostate cancer	3.72e-05	0.000317	CcSEcCtD
Mifepristone—Chills—Epirubicin—prostate cancer	3.71e-05	0.000315	CcSEcCtD
Mifepristone—Pruritus—Etoposide—prostate cancer	3.7e-05	0.000315	CcSEcCtD
Mifepristone—Nervous system disorder—Prednisone—prostate cancer	3.68e-05	0.000313	CcSEcCtD
Mifepristone—Decreased appetite—Capecitabine—prostate cancer	3.66e-05	0.000312	CcSEcCtD
Mifepristone—Skin disorder—Prednisone—prostate cancer	3.64e-05	0.00031	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Capecitabine—prostate cancer	3.64e-05	0.00031	CcSEcCtD
Mifepristone—Fatigue—Capecitabine—prostate cancer	3.63e-05	0.000309	CcSEcCtD
Mifepristone—Mental disorder—Epirubicin—prostate cancer	3.62e-05	0.000308	CcSEcCtD
Mifepristone—Constipation—Capecitabine—prostate cancer	3.6e-05	0.000307	CcSEcCtD
Mifepristone—Pain—Capecitabine—prostate cancer	3.6e-05	0.000307	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—prostate cancer	3.6e-05	0.000306	CcSEcCtD
Mifepristone—Feeling abnormal—Docetaxel—prostate cancer	3.59e-05	0.000305	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—prostate cancer	3.58e-05	0.000305	CcSEcCtD
Mifepristone—Anorexia—Prednisone—prostate cancer	3.58e-05	0.000304	CcSEcCtD
Mifepristone—Gastrointestinal pain—Docetaxel—prostate cancer	3.56e-05	0.000303	CcSEcCtD
Mifepristone—Back pain—Epirubicin—prostate cancer	3.48e-05	0.000296	CcSEcCtD
Mifepristone—Feeling abnormal—Capecitabine—prostate cancer	3.47e-05	0.000295	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—prostate cancer	3.47e-05	0.000295	CcSEcCtD
Mifepristone—Dizziness—Etoposide—prostate cancer	3.46e-05	0.000295	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—prostate cancer	3.46e-05	0.000294	CcSEcCtD
Mifepristone—Gastrointestinal pain—Capecitabine—prostate cancer	3.44e-05	0.000293	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—prostate cancer	3.44e-05	0.000293	CcSEcCtD
Mifepristone—Body temperature increased—Docetaxel—prostate cancer	3.44e-05	0.000293	CcSEcCtD
Mifepristone—Abdominal pain—Docetaxel—prostate cancer	3.44e-05	0.000293	CcSEcCtD
Mifepristone—Chills—Doxorubicin—prostate cancer	3.43e-05	0.000292	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Prednisone—prostate cancer	3.42e-05	0.000291	CcSEcCtD
Mifepristone—Insomnia—Prednisone—prostate cancer	3.39e-05	0.000289	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—prostate cancer	3.35e-05	0.000285	CcSEcCtD
Mifepristone—Urticaria—Capecitabine—prostate cancer	3.35e-05	0.000285	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—prostate cancer	3.34e-05	0.000284	CcSEcCtD
Mifepristone—Abdominal pain—Capecitabine—prostate cancer	3.33e-05	0.000283	CcSEcCtD
Mifepristone—Body temperature increased—Capecitabine—prostate cancer	3.33e-05	0.000283	CcSEcCtD
Mifepristone—Vomiting—Etoposide—prostate cancer	3.33e-05	0.000283	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—prostate cancer	3.33e-05	0.000283	CcSEcCtD
Mifepristone—Rash—Etoposide—prostate cancer	3.3e-05	0.000281	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—prostate cancer	3.3e-05	0.000281	CcSEcCtD
Mifepristone—Headache—Etoposide—prostate cancer	3.28e-05	0.000279	CcSEcCtD
Mifepristone—Decreased appetite—Prednisone—prostate cancer	3.26e-05	0.000278	CcSEcCtD
Mifepristone—Malaise—Epirubicin—prostate cancer	3.24e-05	0.000276	CcSEcCtD
Mifepristone—Fatigue—Prednisone—prostate cancer	3.23e-05	0.000275	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—prostate cancer	3.22e-05	0.000274	CcSEcCtD
Mifepristone—Constipation—Prednisone—prostate cancer	3.21e-05	0.000273	CcSEcCtD
Mifepristone—Hypersensitivity—Docetaxel—prostate cancer	3.21e-05	0.000273	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—prostate cancer	3.2e-05	0.000272	CcSEcCtD
Mifepristone—Asthenia—Docetaxel—prostate cancer	3.12e-05	0.000266	CcSEcCtD
Mifepristone—Nausea—Etoposide—prostate cancer	3.11e-05	0.000265	CcSEcCtD
Mifepristone—Hypertension—Epirubicin—prostate cancer	3.1e-05	0.000264	CcSEcCtD
Mifepristone—Hypersensitivity—Capecitabine—prostate cancer	3.1e-05	0.000264	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisone—prostate cancer	3.09e-05	0.000263	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—prostate cancer	3.09e-05	0.000263	CcSEcCtD
Mifepristone—Pruritus—Docetaxel—prostate cancer	3.08e-05	0.000262	CcSEcCtD
Mifepristone—Gastrointestinal pain—Prednisone—prostate cancer	3.07e-05	0.000261	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—prostate cancer	3.06e-05	0.000261	CcSEcCtD
Mifepristone—Myalgia—Epirubicin—prostate cancer	3.06e-05	0.000261	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—prostate cancer	3.05e-05	0.00026	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.04e-05	0.000259	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—prostate cancer	3.02e-05	0.000257	CcSEcCtD
Mifepristone—Asthenia—Capecitabine—prostate cancer	3.02e-05	0.000257	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—prostate cancer	3e-05	0.000255	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—prostate cancer	2.99e-05	0.000255	CcSEcCtD
Mifepristone—Urticaria—Prednisone—prostate cancer	2.98e-05	0.000254	CcSEcCtD
Mifepristone—Pruritus—Capecitabine—prostate cancer	2.98e-05	0.000254	CcSEcCtD
Mifepristone—Diarrhoea—Docetaxel—prostate cancer	2.98e-05	0.000253	CcSEcCtD
Mifepristone—Abdominal pain—Prednisone—prostate cancer	2.97e-05	0.000252	CcSEcCtD
Mifepristone—Body temperature increased—Prednisone—prostate cancer	2.97e-05	0.000252	CcSEcCtD
Mifepristone—Oedema—Epirubicin—prostate cancer	2.93e-05	0.00025	CcSEcCtD
Mifepristone—Infection—Epirubicin—prostate cancer	2.92e-05	0.000248	CcSEcCtD
Mifepristone—Diarrhoea—Capecitabine—prostate cancer	2.88e-05	0.000245	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—prostate cancer	2.88e-05	0.000245	CcSEcCtD
Mifepristone—Dizziness—Docetaxel—prostate cancer	2.88e-05	0.000245	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—prostate cancer	2.87e-05	0.000244	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—prostate cancer	2.85e-05	0.000243	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—prostate cancer	2.83e-05	0.000241	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—prostate cancer	2.83e-05	0.000241	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—prostate cancer	2.82e-05	0.00024	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.81e-05	0.000239	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—prostate cancer	2.8e-05	0.000238	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—prostate cancer	2.8e-05	0.000238	CcSEcCtD
Mifepristone—Dizziness—Capecitabine—prostate cancer	2.79e-05	0.000237	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—prostate cancer	2.77e-05	0.000236	CcSEcCtD
Mifepristone—Vomiting—Docetaxel—prostate cancer	2.77e-05	0.000235	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisone—prostate cancer	2.76e-05	0.000235	CcSEcCtD
Mifepristone—Rash—Docetaxel—prostate cancer	2.74e-05	0.000233	CcSEcCtD
Mifepristone—Hypotension—Epirubicin—prostate cancer	2.74e-05	0.000233	CcSEcCtD
Mifepristone—Dermatitis—Docetaxel—prostate cancer	2.74e-05	0.000233	CcSEcCtD
Mifepristone—Headache—Docetaxel—prostate cancer	2.73e-05	0.000232	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—prostate cancer	2.72e-05	0.000231	CcSEcCtD
Mifepristone—Infection—Doxorubicin—prostate cancer	2.7e-05	0.00023	CcSEcCtD
Mifepristone—Asthenia—Prednisone—prostate cancer	2.69e-05	0.000229	CcSEcCtD
Mifepristone—Vomiting—Capecitabine—prostate cancer	2.68e-05	0.000228	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.67e-05	0.000228	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—prostate cancer	2.66e-05	0.000227	CcSEcCtD
Mifepristone—Rash—Capecitabine—prostate cancer	2.66e-05	0.000226	CcSEcCtD
Mifepristone—Pruritus—Prednisone—prostate cancer	2.65e-05	0.000226	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—prostate cancer	2.65e-05	0.000226	CcSEcCtD
Mifepristone—Dermatitis—Capecitabine—prostate cancer	2.65e-05	0.000226	CcSEcCtD
Mifepristone—Headache—Capecitabine—prostate cancer	2.64e-05	0.000225	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—prostate cancer	2.64e-05	0.000224	CcSEcCtD
Mifepristone—Dyspnoea—Epirubicin—prostate cancer	2.62e-05	0.000223	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—prostate cancer	2.61e-05	0.000222	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—prostate cancer	2.59e-05	0.00022	CcSEcCtD
Mifepristone—Nausea—Docetaxel—prostate cancer	2.58e-05	0.00022	CcSEcCtD
Mifepristone—Diarrhoea—Prednisone—prostate cancer	2.57e-05	0.000219	CcSEcCtD
Mifepristone—Decreased appetite—Epirubicin—prostate cancer	2.55e-05	0.000217	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—prostate cancer	2.54e-05	0.000216	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—prostate cancer	2.53e-05	0.000216	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—prostate cancer	2.53e-05	0.000215	CcSEcCtD
Mifepristone—Constipation—Epirubicin—prostate cancer	2.51e-05	0.000214	CcSEcCtD
Mifepristone—Pain—Epirubicin—prostate cancer	2.51e-05	0.000214	CcSEcCtD
Mifepristone—Nausea—Capecitabine—prostate cancer	2.5e-05	0.000213	CcSEcCtD
Mifepristone—Dizziness—Prednisone—prostate cancer	2.48e-05	0.000211	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.47e-05	0.000211	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—prostate cancer	2.46e-05	0.000209	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—prostate cancer	2.42e-05	0.000206	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—prostate cancer	2.42e-05	0.000206	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—prostate cancer	2.41e-05	0.000205	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—prostate cancer	2.4e-05	0.000204	CcSEcCtD
Mifepristone—Vomiting—Prednisone—prostate cancer	2.39e-05	0.000203	CcSEcCtD
Mifepristone—Rash—Prednisone—prostate cancer	2.37e-05	0.000201	CcSEcCtD
Mifepristone—Dermatitis—Prednisone—prostate cancer	2.36e-05	0.000201	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—prostate cancer	2.36e-05	0.000201	CcSEcCtD
Mifepristone—Headache—Prednisone—prostate cancer	2.35e-05	0.0002	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.34e-05	0.0002	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—prostate cancer	2.34e-05	0.000199	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—prostate cancer	2.33e-05	0.000198	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—prostate cancer	2.32e-05	0.000198	CcSEcCtD
Mifepristone—Pain—Doxorubicin—prostate cancer	2.32e-05	0.000198	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—prostate cancer	2.32e-05	0.000197	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—prostate cancer	2.32e-05	0.000197	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—prostate cancer	2.24e-05	0.00019	CcSEcCtD
Mifepristone—Nausea—Prednisone—prostate cancer	2.23e-05	0.00019	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—prostate cancer	2.22e-05	0.000189	CcSEcCtD
Mifepristone—Hypersensitivity—Epirubicin—prostate cancer	2.16e-05	0.000184	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—prostate cancer	2.16e-05	0.000184	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—prostate cancer	2.15e-05	0.000183	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—prostate cancer	2.15e-05	0.000183	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—prostate cancer	2.11e-05	0.000179	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—prostate cancer	2.08e-05	0.000177	CcSEcCtD
Mifepristone—Diarrhoea—Epirubicin—prostate cancer	2.01e-05	0.000171	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—prostate cancer	2e-05	0.00017	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—prostate cancer	1.95e-05	0.000166	CcSEcCtD
Mifepristone—Dizziness—Epirubicin—prostate cancer	1.94e-05	0.000165	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—prostate cancer	1.92e-05	0.000164	CcSEcCtD
Mifepristone—Vomiting—Epirubicin—prostate cancer	1.87e-05	0.000159	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—prostate cancer	1.86e-05	0.000158	CcSEcCtD
Mifepristone—Rash—Epirubicin—prostate cancer	1.85e-05	0.000157	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—prostate cancer	1.85e-05	0.000157	CcSEcCtD
Mifepristone—Headache—Epirubicin—prostate cancer	1.84e-05	0.000156	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—prostate cancer	1.8e-05	0.000153	CcSEcCtD
Mifepristone—Nausea—Epirubicin—prostate cancer	1.74e-05	0.000148	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—prostate cancer	1.73e-05	0.000147	CcSEcCtD
Mifepristone—Rash—Doxorubicin—prostate cancer	1.71e-05	0.000146	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—prostate cancer	1.71e-05	0.000146	CcSEcCtD
Mifepristone—Headache—Doxorubicin—prostate cancer	1.7e-05	0.000145	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—prostate cancer	1.61e-05	0.000137	CcSEcCtD
Mifepristone—CYP3A5—Metabolism—NCOA1—prostate cancer	2.83e-06	3.85e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PHGDH—prostate cancer	2.82e-06	3.84e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ARG2—prostate cancer	2.82e-06	3.84e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—UMPS—prostate cancer	2.82e-06	3.84e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MDM2—prostate cancer	2.82e-06	3.83e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—prostate cancer	2.81e-06	3.82e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ACHE—prostate cancer	2.81e-06	3.82e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGF2—prostate cancer	2.81e-06	3.82e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—prostate cancer	2.79e-06	3.8e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP19A1—prostate cancer	2.79e-06	3.79e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—prostate cancer	2.78e-06	3.78e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2A6—prostate cancer	2.77e-06	3.78e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LDHB—prostate cancer	2.77e-06	3.77e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS3—prostate cancer	2.77e-06	3.77e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SERPINE1—prostate cancer	2.76e-06	3.76e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CB—prostate cancer	2.74e-06	3.73e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HPGDS—prostate cancer	2.73e-06	3.71e-05	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.72e-06	3.71e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.72e-06	3.7e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2C19—prostate cancer	2.71e-06	3.69e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKR1C3—prostate cancer	2.7e-06	3.68e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—RXRA—prostate cancer	2.69e-06	3.66e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JAK2—prostate cancer	2.69e-06	3.66e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PRKACB—prostate cancer	2.69e-06	3.66e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CAV1—prostate cancer	2.67e-06	3.64e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP17A1—prostate cancer	2.66e-06	3.62e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—prostate cancer	2.65e-06	3.6e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ACHE—prostate cancer	2.65e-06	3.6e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—INS—prostate cancer	2.64e-06	3.6e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—prostate cancer	2.63e-06	3.58e-05	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.63e-06	3.58e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MDM2—prostate cancer	2.62e-06	3.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TCN2—prostate cancer	2.62e-06	3.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—UCP3—prostate cancer	2.62e-06	3.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PDHA1—prostate cancer	2.62e-06	3.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA3—prostate cancer	2.62e-06	3.57e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2A6—prostate cancer	2.61e-06	3.56e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—COMT—prostate cancer	2.59e-06	3.53e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CREBBP—prostate cancer	2.59e-06	3.52e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—prostate cancer	2.59e-06	3.52e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTP1—prostate cancer	2.58e-06	3.51e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—prostate cancer	2.57e-06	3.5e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CB—prostate cancer	2.55e-06	3.48e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKR1C3—prostate cancer	2.54e-06	3.46e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ITPR1—prostate cancer	2.54e-06	3.45e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NCOA2—prostate cancer	2.53e-06	3.45e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PRKACB—prostate cancer	2.53e-06	3.45e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—prostate cancer	2.53e-06	3.45e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—prostate cancer	2.52e-06	3.43e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—prostate cancer	2.52e-06	3.43e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP17A1—prostate cancer	2.5e-06	3.41e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.5e-06	3.41e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.5e-06	3.41e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CD—prostate cancer	2.45e-06	3.34e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—prostate cancer	2.45e-06	3.34e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—prostate cancer	2.43e-06	3.31e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—prostate cancer	2.43e-06	3.31e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC5A5—prostate cancer	2.42e-06	3.29e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA4—prostate cancer	2.4e-06	3.27e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.4e-06	3.27e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMS—prostate cancer	2.4e-06	3.26e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—prostate cancer	2.4e-06	3.26e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NCOA2—prostate cancer	2.39e-06	3.25e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—prostate cancer	2.38e-06	3.24e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—prostate cancer	2.37e-06	3.23e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—prostate cancer	2.37e-06	3.23e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—prostate cancer	2.37e-06	3.22e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2E1—prostate cancer	2.36e-06	3.21e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA2—prostate cancer	2.34e-06	3.18e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NQO1—prostate cancer	2.33e-06	3.18e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—LPL—prostate cancer	2.33e-06	3.17e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NOS3—prostate cancer	2.32e-06	3.15e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.31e-06	3.14e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCG5—prostate cancer	2.31e-06	3.14e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—prostate cancer	2.31e-06	3.14e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—INS—prostate cancer	2.3e-06	3.14e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TH—prostate cancer	2.3e-06	3.13e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.28e-06	3.1e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP3A4—prostate cancer	2.28e-06	3.1e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—prostate cancer	2.26e-06	3.08e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—prostate cancer	2.26e-06	3.07e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CREBBP—prostate cancer	2.26e-06	3.07e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTA1—prostate cancer	2.26e-06	3.07e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.25e-06	3.06e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1B1—prostate cancer	2.24e-06	3.05e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NAT2—prostate cancer	2.23e-06	3.04e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.23e-06	3.04e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTO1—prostate cancer	2.23e-06	3.04e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ERCC2—prostate cancer	2.23e-06	3.03e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.22e-06	3.03e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—prostate cancer	2.21e-06	3.01e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—prostate cancer	2.21e-06	3e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NQO1—prostate cancer	2.2e-06	2.99e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SRC—prostate cancer	2.2e-06	2.99e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TH—prostate cancer	2.17e-06	2.95e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GGT1—prostate cancer	2.17e-06	2.95e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.14e-06	2.92e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.14e-06	2.91e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PLCB2—prostate cancer	2.14e-06	2.91e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.14e-06	2.91e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LRP2—prostate cancer	2.14e-06	2.91e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CB—prostate cancer	2.14e-06	2.91e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—prostate cancer	2.14e-06	2.91e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NCOA1—prostate cancer	2.13e-06	2.91e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—prostate cancer	2.12e-06	2.89e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—prostate cancer	2.12e-06	2.88e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.11e-06	2.87e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—prostate cancer	2.1e-06	2.87e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP19A1—prostate cancer	2.1e-06	2.86e-05	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—prostate cancer	2.1e-06	2.86e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—P4HB—prostate cancer	2.1e-06	2.86e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—prostate cancer	2.09e-06	2.85e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARA—prostate cancer	2.05e-06	2.8e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SRC—prostate cancer	2.05e-06	2.79e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GGT1—prostate cancer	2.04e-06	2.78e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.04e-06	2.78e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—RXRA—prostate cancer	2.03e-06	2.76e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NOS3—prostate cancer	2.02e-06	2.75e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NCOA1—prostate cancer	2.01e-06	2.74e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.99e-06	2.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.98e-06	2.7e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—prostate cancer	1.97e-06	2.69e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—prostate cancer	1.97e-06	2.68e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—prostate cancer	1.96e-06	2.67e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MED12—prostate cancer	1.96e-06	2.66e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—COMT—prostate cancer	1.96e-06	2.66e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTP1—prostate cancer	1.95e-06	2.65e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GNG5—prostate cancer	1.94e-06	2.64e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CAV1—prostate cancer	1.93e-06	2.63e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—prostate cancer	1.92e-06	2.62e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ITPR1—prostate cancer	1.91e-06	2.61e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—RXRA—prostate cancer	1.91e-06	2.6e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.87e-06	2.55e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CB—prostate cancer	1.87e-06	2.54e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—prostate cancer	1.85e-06	2.52e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—prostate cancer	1.85e-06	2.52e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—COMT—prostate cancer	1.84e-06	2.51e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—prostate cancer	1.83e-06	2.5e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTP1—prostate cancer	1.83e-06	2.5e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—prostate cancer	1.83e-06	2.49e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—prostate cancer	1.82e-06	2.48e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMS—prostate cancer	1.81e-06	2.46e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ITPR1—prostate cancer	1.8e-06	2.46e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—prostate cancer	1.79e-06	2.44e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—prostate cancer	1.79e-06	2.43e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.78e-06	2.43e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.77e-06	2.41e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—prostate cancer	1.76e-06	2.4e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.76e-06	2.4e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—LPL—prostate cancer	1.76e-06	2.39e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—prostate cancer	1.75e-06	2.38e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ACHE—prostate cancer	1.73e-06	2.35e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.73e-06	2.35e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.71e-06	2.33e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMS—prostate cancer	1.7e-06	2.32e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1A1—prostate cancer	1.7e-06	2.31e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—prostate cancer	1.69e-06	2.31e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—prostate cancer	1.69e-06	2.29e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ERCC2—prostate cancer	1.68e-06	2.29e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—prostate cancer	1.67e-06	2.27e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—INS—prostate cancer	1.67e-06	2.27e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.66e-06	2.26e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.65e-06	2.25e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LPL—prostate cancer	1.65e-06	2.25e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.64e-06	2.23e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CREBBP—prostate cancer	1.63e-06	2.22e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—prostate cancer	1.62e-06	2.2e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—prostate cancer	1.61e-06	2.19e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—prostate cancer	1.6e-06	2.18e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.6e-06	2.17e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ERCC2—prostate cancer	1.58e-06	2.16e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—prostate cancer	1.58e-06	2.15e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.56e-06	2.12e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—prostate cancer	1.56e-06	2.12e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARA—prostate cancer	1.55e-06	2.11e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.55e-06	2.11e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—prostate cancer	1.54e-06	2.09e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—prostate cancer	1.49e-06	2.03e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.49e-06	2.03e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—prostate cancer	1.48e-06	2.01e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARA—prostate cancer	1.46e-06	1.99e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NOS3—prostate cancer	1.46e-06	1.99e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CAV1—prostate cancer	1.46e-06	1.98e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.45e-06	1.98e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NQO1—prostate cancer	1.44e-06	1.96e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TH—prostate cancer	1.42e-06	1.93e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—prostate cancer	1.38e-06	1.88e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.38e-06	1.88e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CAV1—prostate cancer	1.37e-06	1.87e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—prostate cancer	1.36e-06	1.86e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.35e-06	1.84e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—prostate cancer	1.34e-06	1.82e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GGT1—prostate cancer	1.33e-06	1.82e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—prostate cancer	1.33e-06	1.81e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.31e-06	1.79e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—prostate cancer	1.3e-06	1.78e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.3e-06	1.76e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—prostate cancer	1.27e-06	1.73e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—INS—prostate cancer	1.26e-06	1.71e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.25e-06	1.7e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—RXRA—prostate cancer	1.25e-06	1.7e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CREBBP—prostate cancer	1.23e-06	1.68e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—prostate cancer	1.21e-06	1.65e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—COMT—prostate cancer	1.2e-06	1.64e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.2e-06	1.63e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—INS—prostate cancer	1.18e-06	1.61e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.18e-06	1.61e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CD—prostate cancer	1.17e-06	1.59e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—prostate cancer	1.17e-06	1.59e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CREBBP—prostate cancer	1.16e-06	1.58e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.14e-06	1.55e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMS—prostate cancer	1.11e-06	1.52e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—prostate cancer	1.11e-06	1.51e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NOS3—prostate cancer	1.1e-06	1.5e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.1e-06	1.5e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.1e-06	1.5e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LPL—prostate cancer	1.08e-06	1.47e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—prostate cancer	1.06e-06	1.45e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.04e-06	1.42e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NOS3—prostate cancer	1.04e-06	1.41e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.04e-06	1.41e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CB—prostate cancer	1.02e-06	1.39e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—prostate cancer	1.01e-06	1.37e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—prostate cancer	9.74e-07	1.33e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CB—prostate cancer	9.59e-07	1.31e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARA—prostate cancer	9.55e-07	1.3e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—prostate cancer	9.5e-07	1.29e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—prostate cancer	9.29e-07	1.26e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CAV1—prostate cancer	8.98e-07	1.22e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—prostate cancer	8.79e-07	1.2e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—prostate cancer	8.38e-07	1.14e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—prostate cancer	8.28e-07	1.13e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—prostate cancer	8.22e-07	1.12e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.18e-07	1.11e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—prostate cancer	7.9e-07	1.08e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—INS—prostate cancer	7.74e-07	1.05e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CREBBP—prostate cancer	7.58e-07	1.03e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.19e-07	9.79e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NOS3—prostate cancer	6.79e-07	9.25e-06	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—prostate cancer	6.71e-07	9.14e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.27e-07	8.53e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—prostate cancer	6.21e-07	8.46e-06	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—prostate cancer	6.2e-07	8.44e-06	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.84e-07	7.96e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—prostate cancer	5.42e-07	7.37e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—prostate cancer	5.17e-07	7.03e-06	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—prostate cancer	5.07e-07	6.9e-06	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—prostate cancer	4.77e-07	6.5e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.82e-07	5.2e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—prostate cancer	3.12e-07	4.25e-06	CbGpPWpGaD
